Gilead Sciences to Release Third Quarter 2018 Financial Results on Thursday, October 25, 2018

On October 12, 2018 Gilead Sciences, Inc. (Nasdaq: GILD) reported that its third quarter 2018 financial results will be released on Thursday, October 25, after the market closes (Press release, Gilead Sciences, OCT 12, 2018, View Source;p=irol-newsArticle&ID=2371354 [SID1234529876]). At 4:30 p.m. Eastern Time, Gilead’s management will host a conference call to discuss the company’s financial results for the third quarter 2018 and provide a general business update.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The live webcast of the call can be accessed at the company’s Investors page at www.gilead.com/investors. Please connect to the company’s website at least 15 minutes prior to the start of the call to ensure adequate time for any software download that may be required to listen to the webcast. Alternatively, please call 877-359-9508 (U.S.) or 224-357-2393 (international) and dial the conference ID 1789278 to access the call. Telephone replay will be available approximately two hours after the call through 11:59 p.m. Eastern Time, October 27, 2018. To access the replay, please call 855-859-2056 (U.S.) or 404-537-3406 (international) and dial the conference ID 1789278. The webcast will be archived on www.gilead.com for one year.